Sophie Waldron
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sophie Waldron has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Dominic Michael Dwyer
School of Psychology, Cardiff University, Cardiff CF10 3AT, UK
2 shared publications - Emma Susan Jane Robinson
School of Physiology, Pharmacology and Neuroscience, Biomedical Sciences Building, University of Bristol, Bristol, England
2 shared publications - Jack R. Mellor
School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK
2 shared publications - Kerrie L. Thomas
Department of Psychological Medicine and Clinical Neuroscience, Cardiff University School of Medicine, Hadyn Ellis Building, Maindy Road, Cardiff, CF24 4HQ
2 shared publications Lawrence S. Wilkinson
Cardiff University
2 shared publications- Simonas Griesius
Department of Clinical Experimental and Epilepsy, UCL Queen Square Institute of Neurology, University College London
2 shared publications
Latest Publications
- Open Access
Intracellular amino acid scarcity sensing tunes protein hunger
Protein is a key macronutrient that strongly governs food intake. Following dietary protein scarcity, animals display compensatory preference for amino acid-rich food, yet how the brain detects and encodes protein hunger remains unclear. To address this question, we used Drosophila melanogaster to investigate the function of peptidergic neurons, a major neuromodulatory cell population that includes key regulators of feeding behaviour and protein homeostasis. We present a high-resolution transcriptional atlas obtained by RNA sequencing of single peptidergic nuclei isolated from the brains of sated and amino acid deprived flies. Consistent with a resource-sparing response, differential expression analysis revealed widespread transcriptional downregulation in the amino acid deprived state. A screen of differently expressed candidates identified Lsp2, a gene encoding an amino acid storage protein, as a regulator of protein intake. Knock down and overexpression experiments demonstrate that Lsp2 levels act as a gauge in a specific population of peptidergic neurons expressing Myoinhibiting peptide precursor (Mip) to modulate protein appetite. We further show that compensatory protein feeding following amino acid deprivation depends on maintaining Mip+ neuron activity within an appropriate range. Our findings reveal that peptidergic neurons can directly sense intracellular protein deficiency and use this information to guide protein intake. By linking amino acid storage to the neuronal control of feeding, this work establishes a foundation for understanding how protein needs are encoded in the brain.
Open AccessIntracellular amino acid scarcity sensing tunes protein hunger
Protein is a key macronutrient that strongly governs food intake. Following dietary protein scarcity, animals display compensatory preference for amino acid-rich food, yet how the brain detects and encodes protein hunger remains unclear. To address this question, we used Drosophila melanogaster to investigate the function of peptidergic neurons, a major neuromodulatory cell population that includes key regulators of feeding behaviour and protein homeostasis. We present a high-resolution transcriptional atlas obtained by RNA sequencing of single peptidergic nuclei isolated from the brains of sated and amino acid deprived flies. Consistent with a resource-sparing response, differential expression analysis revealed widespread transcriptional downregulation in the amino acid deprived state. A screen of differently expressed candidates identified Lsp2, a gene encoding an amino acid storage protein, as a regulator of protein intake. Knock down and overexpression experiments demonstrate that Lsp2 levels act as a gauge in a specific population of peptidergic neurons expressing Myoinhibiting peptide precursor (Mip) to modulate protein appetite. We further show that compensatory protein feeding following amino acid deprivation depends on maintaining Mip+ neuron activity within an appropriate range. Our findings reveal that peptidergic neurons can directly sense intracellular protein deficiency and use this information to guide protein intake. By linking amino acid storage to the neuronal control of feeding, this work establishes a foundation for understanding how protein needs are encoded in the brain.
- Open Access
- 18 August 2022
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 47 (13) , 2181-2183
Not all pre-registrations are equal
- 18 August 2022
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 47 (13) , 2181-2183
Open AccessNot all pre-registrations are equal
- Open Access
Behavioural and molecular characterisation of the Dlg2 haploinsufficiency rat model of genetic risk for psychiatric disorder
Genetic studies implicate disruption to the DLG2 gene in copy number variants as increasing risk for schizophrenia, autism spectrum disorders and intellectual disability. To investigate psychiatric endophenotypes associated with DLG2 haploinsufficiency (and concomitant PSD-93 protein reduction) a novel clinically relevant Dlg2 +/- rat was assessed for abnormalities in anxiety, sensorimotor gating, hedonic reactions, social behaviour, and locomotor response to the N-Methyl-D-aspartic acid receptor antagonist phencyclidine. Dlg gene and protein expression were also investigated to assess model validity. Reductions in PSD-93 messenger RNA and protein were observed in the absence of compensation by other related genes or proteins. Behaviourally Dlg2 +/- rats show potentiated locomotor response to phencyclidine, as is typical of psychotic disorder models, in the absence of deficits in the other behavioural phenotypes assessed here. This shows that the behavioural effects of Dlg2 haploinsufficiency may specifically relate to psychosis vulnerability but are subtle, providing a contrast to the gross deficits in Dlg2 homozygous models (Winkler, et al., 2018; Yoo et al., 2020a) which do not so specifically model the single chromosome DLG2 deletion in carriers of risk-associated copy number variants.
Open AccessBehavioural and molecular characterisation of the Dlg2 haploinsufficiency rat model of genetic risk for psychiatric disorder
Genetic studies implicate disruption to the DLG2 gene in copy number variants as increasing risk for schizophrenia, autism spectrum disorders and intellectual disability. To investigate psychiatric endophenotypes associated with DLG2 haploinsufficiency (and concomitant PSD-93 protein reduction) a novel clinically relevant Dlg2 +/- rat was assessed for abnormalities in anxiety, sensorimotor gating, hedonic reactions, social behaviour, and locomotor response to the N-Methyl-D-aspartic acid receptor antagonist phencyclidine. Dlg gene and protein expression were also investigated to assess model validity. Reductions in PSD-93 messenger RNA and protein were observed in the absence of compensation by other related genes or proteins. Behaviourally Dlg2 +/- rats show potentiated locomotor response to phencyclidine, as is typical of psychotic disorder models, in the absence of deficits in the other behavioural phenotypes assessed here. This shows that the behavioural effects of Dlg2 haploinsufficiency may specifically relate to psychosis vulnerability but are subtle, providing a contrast to the gross deficits in Dlg2 homozygous models (Winkler, et al., 2018; Yoo et al., 2020a) which do not so specifically model the single chromosome DLG2 deletion in carriers of risk-associated copy number variants.
- Open Access
Reduced expression of the psychiatric risk gene DLG2 (PSD93) impairs hippocampal synaptic integration and plasticity
Background: Genetic variations indicating loss of function in the DLG2 gene have been associated with markedly increased risk for schizophrenia, autism spectrum disorder, and intellectual disability. DLG2 encodes the postsynaptic scaffolding protein DLG2 (PSD93) that interacts with NMDA receptors, potassium channels, and cytoskeletal regulators but the net impact of these interactions on synaptic plasticity, likely underpinning cognitive impairments associated with these conditions, remains unclear. Methods: Hippocampal CA1 neuronal excitability and synaptic function were investigated in a novel clinically relevant heterozygous Dlg2+/− rat model using ex vivo patch-clamp electrophysiology, pharmacology, and computational modelling. Results: Dlg2+/− rats had increased NMDA receptor-mediated synaptic currents and, conversely, impaired associative long-term potentiation. This impairment resulted from an increase in potassium channel function leading to a decrease in input resistance and reduced supra-linear dendritic integration during induction of associative long-term potentiation. Enhancement of dendritic excitability by blockade of potassium channels or activation of muscarinic M1 receptors with selective allosteric agonist 77-LH-28-1 reduced the threshold for dendritic integration and 77-LH-28-1 rescued the associative long-term potentiation impairment in the Dlg2+/− rats. Conclusions: Despite increasing synaptic NMDA receptor currents, the combined impact of reduced DLG2 impairs synaptic integration in dendrites resulting in disrupted associative synaptic plasticity. This biological phenotype can be reversed by compound classes used clinically such as muscarinic M1 receptor agonists and is therefore a potential target for therapeutic intervention.
Open AccessReduced expression of the psychiatric risk gene DLG2 (PSD93) impairs hippocampal synaptic integration and plasticity
Background: Genetic variations indicating loss of function in the DLG2 gene have been associated with markedly increased risk for schizophrenia, autism spectrum disorder, and intellectual disability. DLG2 encodes the postsynaptic scaffolding protein DLG2 (PSD93) that interacts with NMDA receptors, potassium channels, and cytoskeletal regulators but the net impact of these interactions on synaptic plasticity, likely underpinning cognitive impairments associated with these conditions, remains unclear. Methods: Hippocampal CA1 neuronal excitability and synaptic function were investigated in a novel clinically relevant heterozygous Dlg2+/− rat model using ex vivo patch-clamp electrophysiology, pharmacology, and computational modelling. Results: Dlg2+/− rats had increased NMDA receptor-mediated synaptic currents and, conversely, impaired associative long-term potentiation. This impairment resulted from an increase in potassium channel function leading to a decrease in input resistance and reduced supra-linear dendritic integration during induction of associative long-term potentiation. Enhancement of dendritic excitability by blockade of potassium channels or activation of muscarinic M1 receptors with selective allosteric agonist 77-LH-28-1 reduced the threshold for dendritic integration and 77-LH-28-1 rescued the associative long-term potentiation impairment in the Dlg2+/− rats. Conclusions: Despite increasing synaptic NMDA receptor currents, the combined impact of reduced DLG2 impairs synaptic integration in dendrites resulting in disrupted associative synaptic plasticity. This biological phenotype can be reversed by compound classes used clinically such as muscarinic M1 receptor agonists and is therefore a potential target for therapeutic intervention.